Private Trust Company’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Private Trust Company’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-31	Closed	-$1K	–	2286
2022 Q3	$1K	Buy	+31	New	+$1.33K	﹤0.01%	2001
2014 Q4	–	Sell	-64	Closed	-$3K	–	1209
2014 Q3	$3K	Hold	64	–	–	﹤0.01%	1510
2014 Q2	$3K	Hold	64	–	–	﹤0.01%	1515
2014 Q1	$3K	Hold	64	–	–	﹤0.01%	1386
2013 Q4	$3K	Hold	64	–	–	﹤0.01%	1370
2013 Q3	$2K	Buy	+64	New	+$2.42K	﹤0.01%	1464

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Private Trust Company's XPH Position: Q4 2022 in Review

Private Trust Company sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2022, closing a stake of 31 shares — an estimated $1K sold.

Private Trust Company first reported a position in XPH in Q3 2013 and held it in 6 quarters. The position peaked at $3K in Q3 2014. 73 funds tracked by Wall St. Rank hold XPH as of Q4 2022.

Private Trust Company reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2022 after selling out during the quarter.
Private Trust Company sold 31 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2022, an estimated $1K.
Private Trust Company first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2013 and held it in 6 quarters.
Private Trust Company's State Street SPDR S&P Pharmaceuticals ETF position peaked at $3K in Q3 2014.
73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2022.

Based on Private Trust Company's 13F filing for Q4 2022, filed 18 Jan 2023.